scholarly article | Q13442814 |
P50 | author | Mari-Lynn Drainoni | Q43537707 |
Allen L Gifford | Q56696053 | ||
P2093 | author name string | William N Southern | |
Cindy L Christiansen | |||
Alain H Litwin | |||
Bryce D Smith | |||
Cindy M Weinbaum | |||
Elisa Koppelman | |||
M Diane McKee | |||
P2860 | cites work | Primary care: is there enough time for prevention? | Q24544333 |
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease | Q28194421 | ||
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires | Q29037700 | ||
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
Why don't physicians follow clinical practice guidelines? A framework for improvement | Q29619967 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 | ||
Diagnosis, management, and treatment of hepatitis C | Q29620656 | ||
Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction | Q33773203 | ||
Cost-effectiveness of screening patients for hepatitis C. | Q33827367 | ||
Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review | Q35884609 | ||
Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis | Q37174447 | ||
Guideline-concordant hepatitis C virus testing and notification among patients with and without mental disorders | Q37343042 | ||
Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships | Q39371007 | ||
Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases | Q39411430 | ||
Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project | Q39645918 | ||
Public health impact of antiviral therapy for hepatitis C in the United States | Q39939298 | ||
Measuring adherence to asthma medication regimens | Q40809834 | ||
French consensus conference on hepatitis C: screening and treatment | Q42025728 | ||
Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group | Q42983251 | ||
Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors | Q42984451 | ||
Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. | Q46004991 | ||
Prevalence of hepatitis C among psychiatric patients in the public sector. | Q51951423 | ||
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. | Q51969974 | ||
Evaluation of the effectiveness of targeted lookback for HCV infection in the United States-interim results | Q73149033 | ||
EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement | Q73327648 | ||
Hepatitis C and alcohol | Q73327665 | ||
A symptom of discontent | Q73427019 | ||
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update | Q79302506 | ||
Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes | Q79372504 | ||
Contemporary management of dyslipidemia in high-risk patients: targets still not met | Q80056458 | ||
Association between hospital process performance and outcomes among patients with acute coronary syndromes | Q83202050 | ||
Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence | Q84086425 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
P304 | page(s) | 1-9 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Quality Management in Health Care | Q15763657 |
P1476 | title | Physician nonadherence with a hepatitis C screening program | |
P478 | volume | 23 |
Q51817130 | Advancing the Public's Health by Scaling Innovations in Clinical Quality. |
Q38869757 | Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, Florida |
Q42198665 | Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels. |
Q59357649 | Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems |
Q64237696 | Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs |
Q38977007 | HCV Screening Behaviors and Infection Status among Vietnamese Americans |
Q36858890 | High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013. |
Q40047408 | Improving Hepatitis C Identification: Technology Alone Is Not the Answer. |
Q57193075 | Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States |
Q44482116 | Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries |
Q33788620 | Using mHealth technologies to improve the identification of behavioral health problems in urban primary care settings |
Search more.